Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping

scientific article

Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1028650180
P356DOI10.1038/86188
P3181OpenCitations bibliographic resource ID682062
P698PubMed publication ID11276250
P5875ResearchGate publication ID12057639

P50authorMariusz JaskólskiQ11770106
Anders GrubbQ50855618
Maciej KozakQ58147440
P2093author name stringE Jankowska
M Abrahamson
R Janowski
Z Grzonka
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)316-20
P577publication date2001-04-01
P1433published inNature structural biologyQ26842658
P1476titleHuman cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping
P478volume8

Reverse relations

cites work (P2860)
Q896193093D domain swapping in the TIM barrel of the α subunit of Streptococcus pneumoniae tryptophan synthase
Q246449903D domain swapping: as domains continue to swap
Q358046283DSwap: curated knowledgebase of proteins involved in 3D domain swapping
Q53807797A Single Amino Acid in the Hinge Loop Region of the FOXP Forkhead Domain is Significant for Dimerisation.
Q61443307A five-residue motif for the design of domain swapping in proteins
Q47432033A mechanistic model to predict effects of cathepsin B and cystatin C on β-amyloid aggregation and degradation
Q27642242A protein contortionist: core mutations of GB1 that induce dimerization and domain swapping
Q34640009ACHESYM: an algorithm and server for standardized placement of macromolecular models in the unit cell
Q53344121Aberrant expression of cystatin C in prostate cancer is associated with neuroendocrine differentiation.
Q36354413Acidic pH promotes oligomerization and membrane insertion of the BclXL apoptotic repressor
Q47921291Amino-acid composition after loop deletion drives domain swapping
Q58179795Amyloid fibril formation by human stefin B: influence of pH and TFE on fibril growth and morphology
Q35652946Amyloid properties of the mouse egg zona pellucida
Q34756441Amyloid-fibril formation. Proposed mechanisms and relevance to conformational disease
Q35309786Amyloid-like fibrils from a domain-swapping protein feature a parallel, in-register conformation without native-like interactions.
Q30351368Amyloid-like fibrils of ribonuclease A with three-dimensional domain-swapped and native-like structure.
Q36986109An amyloid-forming segment of beta2-microglobulin suggests a molecular model for the fibril
Q34357767Analysis of domain-swapped oligomers reveals local sequence preferences and structural imprints at the linker regions and swapped interfaces
Q47788351Appendant structure plays an important role in amyloidogenic cystatin dimerization prior to domain swapping
Q37410752Application of amide hydrogen/deuterium exchange mass spectrometry for epitope mapping in human cystatin C.
Q27666546Atomic structure of a nanobody-trapped domain-swapped dimer of an amyloidogenic  2-microglobulin variant
Q34377103Biochemistry and clinical role of human cystatin C.
Q92071855Biological Activities of Secretory RNases: Focus on Their Oligomerization to Design Antitumor Drugs
Q42396970CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER'S DISEASE.
Q57740813Carboxy terminal extended phytocystatins are bifunctional inhibitors of papain and legumain cysteine proteinases
Q36136387Cerebral amyloidosis: amyloid subunits, mutants and phenotypes.
Q39313522Characteristics of C-terminal, β-amyloid peptide binding fragment of neuroprotective protease inhibitor, cystatin C.
Q40725030Characterization of a cysteine proteinase inhibitor induced during neuronal cell differentiation
Q46977409Characterization of the dimerization process of a domain-swapped dimeric variant of human pancreatic ribonuclease.
Q35177052Collapse transitions in thermosensitive multi-block copolymers: a Monte Carlo study.
Q27659998Crystal structure of human cystatin C stabilized against amyloid formation
Q34397220Crystal structure of human cystatin D, a cysteine peptidase inhibitor with restricted inhibition profile
Q27639362Crystal structure of the FHA domain of the Chfr mitotic checkpoint protein and its complex with tungstate
Q27642485Crystal structure of the dimeric unswapped form of bovine seminal ribonuclease
Q24291661Crystal structure of the extracellular segment of integrin alpha Vbeta3
Q35596625Crystallization and preliminary X-ray diffraction analysis of Val57 mutants of the amyloidogenic protein human cystatin C.
Q43241222Cystatin C in macular and neuronal degenerations: implications for mechanism(s) of age-related macular degeneration
Q38341202Cystatin C is a disease-associated protein subject to multiple regulation
Q36274319Cystatin F is a biomarker of prion pathogenesis in mice
Q37424088Cystatin SN neutralizes the inhibitory effect of cystatin C on cathepsin B activity
Q44740563Cystatin forms a tetramer through structural rearrangement of domain-swapped dimers prior to amyloidogenesis
Q37696036Cystatin superfamily
Q39662527Cystatins – Extra- and intracellular cysteine protease inhibitors: High-level secretion and uptake of cystatin C in human neuroblastoma cells
Q26860406Cysteine cathepsins: from structure, function and regulation to new frontiers
Q27318382Deciphering the structure, growth and assembly of amyloid-like fibrils using high-speed atomic force microscopy
Q33728524Detection and Alignment of 3D Domain Swapping Proteins Using Angle-Distance Image-Based Secondary Structural Matching Techniques
Q37683390Developmental regulation of synthesis and dimerization of the amyloidogenic protease inhibitor cystatin C in the hematopoietic system.
Q43897439Differences between the prion protein and its homolog Doppel: a partially structured state with implications for scrapie formation
Q36526184Differences in aggregation properties of three site-specific mutants of recombinant human stefin B.
Q52665959Distinct structural changes in wild-type and amyloidogenic chicken cystatin caused by disruption of C95-C115 disulfide bond.
Q42241154Domain swapping and amyloid fibril conformation.
Q47743214Domain swapping of a llama VHH domain builds a crystal-wide beta-sheet structure
Q34447486Double domain swapping in bovine seminal RNase: formation of distinct N- and C-swapped tetramers and multimers with increasing biological activities
Q52950207Effect of environmental conditions on aggregation and fibril formation of barstar.
Q50985492Effect of methionine80 heme coordination on domain swapping of cytochrome c.
Q46098256Essential role of Pro 74 in stefin B amyloid-fibril formation: dual action of cyclophilin A on the process
Q35877781Evaluation of cystatin C activities against HIV
Q36639277Exploring protein aggregation and self-propagation using lattice models: phase diagram and kinetics
Q37519879FAMCS: finding all maximal common substructures in proteins
Q34138249Familial conformational diseases and dementias
Q37635821Fertility defects in mice expressing the L68Q variant of human cystatin C: a role for amyloid in male infertility.
Q48182955Fibrillogenic oligomers of human cystatin C are formed by propagated domain swapping
Q27312912Formation of cystine slipknots in dimeric proteins
Q42265622Fungal lectin MpL enables entry of protein drugs into cancer cells and their subcellular targeting.
Q47605166Gelsolin pathogenic Gly167Arg mutation promotes domain-swap dimerization of the protein
Q36088829Genome-Wide Prediction and Analysis of 3D-Domain Swapped Proteins in the Human Genome from Sequence Information
Q31156451Glycosylation and specific deamidation of ribonuclease B affect the formation of three-dimensional domain-swapped oligomers.
Q44497203High pressure induces the formation of aggregation-prone states of proteins under reducing conditions
Q34053657High throughput testing of drug library substances and monoclonal antibodies for capacity to reduce formation of cystatin C dimers to identify candidates for treatment of hereditary cystatin C amyloid angiopathy.
Q38987127Human cystatin C monomer, dimer, oligomer, and amyloid structures are related to health and disease.
Q34564980Human pancreatitis-associated protein forms fibrillar aggregates with a native-like conformation
Q43875211Human stefin B readily forms amyloid fibrils in vitro
Q47563579Identification and characterization of antibodies elicited by human cystatin C fragment.
Q43057871In vitro study of stability and amyloid-fibril formation of two mutants of human stefin B (cystatin B) occurring in patients with EPM1.
Q41859753Influence of point mutations on the stability, dimerization, and oligomerization of human cystatin C and its L68Q variant
Q50882222Insights into the mechanism of cystatin C oligomer and amyloid formation and its interaction with β-amyloid.
Q34862258Integrin structure: new twists and turns in dynamic cell adhesion
Q33661328Interaction between oligomers of stefin B and amyloid-beta in vitro and in cells.
Q43999627Interaction of serum amyloid A with human cystatin C--assessment of amino acid residues crucial for hCC-SAA formation (part II).
Q44530124Interaction of serum amyloid A with human cystatin C--identification of binding sites.
Q49885401Involvement of Cystatin C in Immunity and Apoptosis.
Q48287384Isolation and characterization of autoantibodies against human cystatin C.
Q38557771Journey of cystatins from being mere thiol protease inhibitors to at heart of many pathological conditions
Q35712841Ligand binding and membrane insertion compete with oligomerization of the BclXL apoptotic repressor
Q26749121Lysosomal cathepsins and their regulation in aging and neurodegeneration
Q42428466Mapping local structural perturbations in the native state of stefin B (cystatin B) under amyloid forming conditions.
Q37871074Mechanisms of amyloid fibril formation--focus on domain-swapping
Q36609753Mechanistic biomarkers for cytotoxic acute kidney injury
Q51334586Modelling family 2 cystatins and their interaction with papain.
Q30497091Molecular determinants of improved cathepsin B inhibition by new cystatins obtained by DNA shuffling
Q30165046Molecular dynamics simulation of the SH3 domain aggregation suggests a generic amyloidogenesis mechanism
Q45796784Molecular dynamics simulation to investigate the impact of disulfide bond formation on conformational stability of chicken cystatin I66Q mutant
Q42629832Molecular dynamics simulations of human cystatin C and its L68Q varient to investigate the domain swapping mechanism
Q51024224Molecular dynamics simulations to investigate the domain swapping mechanism of human cystatin C.
Q50467116Monomers of the NhaA Na+/H+ antiporter of Escherichia coli are fully functional yet dimers are beneficial under extreme stress conditions at alkaline pH in the presence of Na+ or Li+.
Q34452395Oligomerization and aggregation of bovine pancreatic ribonuclease A: characteristic events observed by FTIR spectroscopy
Q46220803Oligomerization and transglutaminase cross-linking of the cystatin CRES in the mouse epididymal lumen: potential mechanism of extracellular quality control
Q34315788Oligomerization of bovine ribonuclease A: structural and functional features of its multimers
Q44952066Oligomerization of ribonuclease A: two novel three-dimensional domain-swapped tetramers
Q21256421On the origin of the histone fold
Q40320734Open interface and large quaternary structure movements in 3D domain swapped proteins: insights from molecular dynamics simulations of the C-terminal swapped dimer of ribonuclease A.
Q38617150Partial rotational lattice order-disorder in stefin B crystals.
Q30417671Pressure as a denaturing agent in studies of single-point mutants of an amyloidogenic protein human cystatin c.
Q41275437Pretreatment Serum Cystatin C Levels Predict Renal Function, but Not Tumor Characteristics, in Patients with Prostate Neoplasia.
Q33232435Prevention of amyloid fibril formation of amyloidogenic chicken cystatin by site-specific glycosylation in yeast
Q33199753Prevention of domain swapping inhibits dimerization and amyloid fibril formation of cystatin C: use of engineered disulfide bridges, antibodies, and carboxymethylpapain to stabilize the monomeric form of cystatin C.
Q42378672Production of Cystatin C Wild Type and Stabilized Mutants
Q42105214Proline Residues as Switches in Conformational Changes Leading to Amyloid Fibril Formation
Q43093815Protein aggregation determinants from a simplified model: cooperative folders resist aggregation
Q34525881Protein folding and three-dimensional domain swapping: a strained relationship?
Q30365413Protein reconstitution and three-dimensional domain swapping: benefits and constraints of covalency.
Q33920260Protein-folding landscapes in multichain systems.
Q48098677Proteomics identification of proteins in human cortex using multidimensional separations and MALDI tandem mass spectrometer
Q27336041Rapid sampling of molecular motions with prior information constraints
Q50931817Rational design of a low-affinity peptide for the detection of cystatin C in a fast homogeneous immunoassay.
Q27696139Rational design of heterodimeric protein using domain swapping for myoglobin
Q41987667Regions which are Responsible for Swapping are also Responsible for Folding and Misfolding
Q34650054Runaway domain swapping in amyloid-like fibrils of T7 endonuclease I.
Q30365734Self-assembly of human latexin into amyloid-like oligomers.
Q52012637Sequence-structure signals of 3D domain swapping in proteins.
Q34932013Serpinopathies and the conformational dementias
Q55382081Serum Cystatin C Level Is Not a Promising Biomarker for Predicting Clinicopathological Characteristics of Bladder Urothelial Tumors.
Q57186606Similar toxicity of the oligomeric molten globule state and the prefibrillar oligomers
Q43477001Size and morphology of toxic oligomers of amyloidogenic proteins: a case study of human stefin B.
Q36910057Stabilization, characterization, and selective removal of cystatin C amyloid oligomers.
Q46161037Steered molecular dynamics simulation of the binding of the β2 and β3 regions in domain-swapped human cystatin C dimer
Q47579578Steered molecular dynamics simulations on the binding of the appendant structure and helix-β2 in domain-swapped human cystatin C dimer
Q43189990Structural and dynamic properties of a new amyloidogenic chicken cystatin mutant I108T.
Q89392305Structural and functional analysis of cystatin E reveals enzymologically relevant dimer and amyloid fibril states
Q34511593Structural basis of reduction-dependent activation of human cystatin F.
Q27676957Structural characterization of V57D and V57P mutants of human cystatin C, an amyloidogenic protein
Q34947293Structural insights into functional and pathological amyloid
Q36693082Structural models of amyloid-like fibrils
Q36129094Structure and aggregation mechanism of beta(2)-microglobulin (83-99) peptides studied by molecular dynamics simulations
Q28084296The Landscape of Intertwined Associations in Homooligomeric Proteins
Q27680786The Multidrug Resistance IncA/C Transferable Plasmid Encodes a Novel Domain-swapped Dimeric Protein-disulfide Isomerase
Q35591691The activity of TcCYS4 modified by variations in pH and temperature can affect symptoms of witches' broom disease of cocoa, caused by the fungus Moniliophthora perniciosa
Q27662251The crystal structures of two salivary cystatins from the tick Ixodes scapularis and the effect of these inhibitors on the establishment of Borrelia burgdorferi infection in a murine model
Q64994075The domain swapping of human cystatin C induced by synchrotron radiation.
Q27639001The domain-swapped dimer of cyanovirin-N is in a metastable folded state: reconciliation of X-ray and NMR structures
Q30165352The dual role of a loop with low loop contact distance in folding and domain swapping
Q45872079The mammalian DUF59 protein Fam96a forms two distinct types of domain-swapped dimer
Q37014900The method of purifying bioengineered spider silk determines the silk sphere properties.
Q28307028The role of cystatin C in cerebral amyloid angiopathy and stroke: cell biology and animal models
Q36650672The role of cystatins in cells of the immune system
Q34177517The role of dimerization in prion replication
Q36596587The structural biology of protein aggregation diseases: Fundamental questions and some answers
Q35080182The unfolding story of three-dimensional domain swapping.
Q44281858Thermal aggregation of ribonuclease A. A contribution to the understanding of the role of 3D domain swapping in protein aggregation
Q44743859Thermal and guanidine hydrochloride-induced denaturation of human cystatin C.
Q27687002Three-dimensional domain swapping and supramolecular protein assembly: insights from the X-ray structure of a dimeric swapped variant of human pancreatic RNase
Q27634658Three-dimensional domain swapping in the folded and molten-globule states of cystatins, an amyloid-forming structural superfamily
Q43205499Trinucleotide expansions leading to an extended poly-L-alanine segment in the poly (A) binding protein PABPN1 cause fibril formation
Q42943805Two new types of assays to determine protein concentrations in biological fluids using mass spectrometry of intact proteins with cystatin C in spinal fluid as an example
Q42377050Ubiquitin Linkage-Specific Affimers Reveal Insights into K6-Linked Ubiquitin Signaling
Q53026162Unbinding and unfolding of adhesion protein complexes through stretching: interplay between shear and tensile mechanical clamps.
Q33368470Viral cystatin evolution and three-dimensional structure modelling: a case of directional selection acting on a viral protein involved in a host-parasitoid interaction
Q30382591Wetting of nonconserved residue-backbones: A feature indicative of aggregation associated regions of proteins.
Q27683605X-ray crystallography and NMR studies of domain-swapped canecystatin-1
Q27666185β2-microglobulin forms three-dimensional domain-swapped amyloid fibrils with disulfide linkages

Search more.